Market Overview

Benzinga's Top #PreMarket Gainers

Related OMED
OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog
OncoMed's OMP-18R5 On Clinical Hold, Shares Down - Analyst Blog
Related CELG
Two Analysts Don't See Celgene's Weak Trial Results As A Huge Setback
Celgene Slips; Drug Candidate Fails Phase III Trial Endpoint

OncoMed Pharmaceuticals (NASDAQ: OMED) surged 80.40% to $25.40 in the pre-market session on deal to sell 1.47 million shares to Celgene (NASDAQ: CELG) at $15.13 per share.

Conatus Pharmaceuticals (NASDAQ: CNAT) shares gained 25.57% to $7.71 in the pre-market as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.

Unilife (NASDAQ: UNIS) soared 20% to $4.98 in the pre-market trading after the company announced clinical supply agreement with Novartis (NYSE: NVS) for delivery of a novel drug.

Tesla Motors (NASDAQ: TSLA) shares jumped 5.92% to $131.52 in pre-market trading after the company announced that the German regulator has closed review of Model S incidents. Morgan Stanley named the stock a Top Pick in the auto sector.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Most Popular

Related Articles (CELG + CNAT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free